Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Medicina Tropical
versión On-line ISSN 1561-3054
Resumen
MONTALVO VILLALBA, María Caridad et al. Evaluation of the clinical performance of the SUMASIGNAL HCV assay for detection of hepatitis C virus RNA. Rev Cubana Med Trop [online]. 2021, vol.73, n.3 Epub 01-Dic-2021. ISSN 1561-3054.
Introduction:
Detection and quantification of the hepatitis C virus genome (HCV RNA) by real time reverse transcription PCR (RT-qPCR) are vital for the diagnosis and antiviral treatment follow-up of hepatitis C patients.
Objective:
Evaluate the clinical performance of the SUMASIGNAL HCV assay for quantification of HCV viral load.
Methods:
A panel was formed with 70 serum samples: 46 HCV RNA positive, 12 HCV RNA negative and 12 positive for molecular markers of other viruses. Pearson's correlation coefficient (r) and the Bland-Altman plot were used to compare the HCV viral loads obtained by SUMASIGNAL HCV techniques with reference values, which were expressed as base 10 logarithm (log10) UI/ml. Values of p <0.05 were considered statistically significant.
Results:
The clinical sensitivity and specificity of SUMASIGNAL HVC were 100%, and no cross-reactivity was detected with the other viruses evaluated. The study assay exhibited a good correlation (r= 0.89) and strong concordance (mean= -0.01 Log10 UI/ml) with the reference test (p< 0.0001). Reproducibility of the HCV RNA quantification with the SUMASIGNAL HCV test at two different moments displayed an excellent correlation (r= 0.97; p< 0.0001).
Conclusions:
The SUMASIGNAL HVC assay provides valid, reproducible and technically reliable data for specific HCV diagnosis. It is also a useful tool to monitor the viral load of this agent in the Cuban National Health System.
Palabras clave : hepatitis C virus; viral load; real time polymerase chain reaction; performance evaluation.